Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MAISSAA JANBAIN

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1962668707
CMS profile
89407
Location
NEW ORLEANS, LA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$268,926.65

147 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
GENZYME CORPORATION $157,429.95 71
HEMA Biologics, LLC $29,120.08 15
BioMarin Pharmaceutical Inc. $26,241.36 19
SANOFI-AVENTIS U.S. LLC $21,470.66 8
CSL Behring $20,894.86 18
Genentech USA, Inc. $6,581.96 8
Takeda Pharmaceuticals U.S.A., Inc. $5,658.88 2
Bayer Healthcare Pharmaceuticals Inc. $1,396.38 3
Regeneron Pharmaceuticals, Inc. $91.02 1
PFIZER INC. $41.50 2

Page 3 of 3; records 101–147 of 147 matching records. This page contains 47 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MAISSAA JANBAIN

NPI 1962668707 · CMS profile ID 89407

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

NEW ORLEANS, LA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–147 of 147 matching records. This page contains 47 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1962668707?year=2024&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MAISSAA JANBAIN, NPI 1962668707, CMS profile ID 89407. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–147 of 147 matching records. This page contains 47 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1962668707?year=2024&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). MAISSAA JANBAIN, NPI 1962668707, CMS profile ID 89407. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–147 of 147 matching records. This page contains 47 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1962668707?year=2024&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
MAISSAA JANBAIN, NPI 1962668707, CMS profile ID 89407, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–147 of 147 matching records. This page contains 47 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1962668707?year=2024&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

147 matching records · $268,926.65 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 147 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–147 of 147.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
GENZYME CORPORATION $9,776.0006/01/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139814611 CMS
GENZYME CORPORATION $495.4306/01/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139814613 CMS
GENZYME CORPORATION $380.3106/01/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139814615 CMS
GENZYME CORPORATION $3,988.0005/31/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139814599 CMS
GENZYME CORPORATION $121.8105/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139814601 CMS
GENZYME CORPORATION $988.5005/21/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139814621 CMS
GENZYME CORPORATION $148.7705/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139814573 CMS
GENZYME CORPORATION $8,567.0005/15/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139814575 CMS
GENZYME CORPORATION $167.9005/15/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139814577 CMS
GENZYME CORPORATION $448.2005/15/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139814579 CMS
GENZYME CORPORATION $397.2605/15/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139814581 CMS
GENZYME CORPORATION $22.0005/15/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139814583 CMS
CSL Behring $4,760.0005/09/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1134639511 CMS
CSL Behring $477.2005/04/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1134639507 CMS
CSL Behring $1,218.2305/04/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1134639509 CMS
CSL Behring $1,120.0004/18/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1134639505 CMS
GENZYME CORPORATION $2,966.0004/10/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139814571 CMS
Takeda Pharmaceuticals U.S.A., Inc. $3,651.3804/08/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1137587595 CMS
Bayer Healthcare Pharmaceuticals Inc. $2.7004/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086090715 CMS
Bayer Healthcare Pharmaceuticals Inc. $83.6804/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086130554 CMS
CSL Behring $1,680.0003/20/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1134639503 CMS
GENZYME CORPORATION $1,647.5003/08/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139814569 CMS
CSL Behring $4,760.0003/07/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1134639499 CMS
CSL Behring $36.7303/07/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1134639501 CMS
CSL Behring $90.5402/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1134639491 CMS
CSL Behring $114.9102/27/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1134639493 CMS
CSL Behring $285.7502/27/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1134639495 CMS
CSL Behring $342.2102/27/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1134639497 CMS
CSL Behring $1,120.0002/22/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1134639489 CMS
SANOFI-AVENTIS U.S. LLC $83.0902/11/2024 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1155227448 CMS
SANOFI-AVENTIS U.S. LLC $97.6502/11/2024 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1155227450 CMS
SANOFI-AVENTIS U.S. LLC $52.8202/11/2024 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1155227452 CMS
SANOFI-AVENTIS U.S. LLC $192.0002/11/2024 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1155227454 CMS
SANOFI-AVENTIS U.S. LLC $419.0002/11/2024 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1155227456 CMS
SANOFI-AVENTIS U.S. LLC $268.8502/11/2024 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1155227458 CMS
SANOFI-AVENTIS U.S. LLC $513.2502/11/2024 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1155227460 CMS
SANOFI-AVENTIS U.S. LLC $19,844.0002/11/2024 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1155227462 CMS
GENZYME CORPORATION $27.6502/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139814533 CMS
GENZYME CORPORATION $8,238.0002/02/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139814553 CMS
GENZYME CORPORATION $717.9602/02/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139814555 CMS
GENZYME CORPORATION $536.9002/02/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139814557 CMS
GENZYME CORPORATION $121.4201/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139814559 CMS
GENZYME CORPORATION $8,238.0001/31/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139814561 CMS
GENZYME CORPORATION $190.0201/31/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139814563 CMS
GENZYME CORPORATION $573.5501/31/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139814565 CMS
GENZYME CORPORATION $234.5001/31/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139814567 CMS
GENZYME CORPORATION $3,954.0001/29/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139814679 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $35,105.60 50
PY2020 $22,591.72 16
PY2021 $28,517.65 22
PY2022 $70,373.84 66
PY2023 $209,026.60 170
PY2024 $268,926.65 147
PY2025 $226,998.22 128

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $11,730.00 2
PY2025 Principal investigator $36,639.00 6
PY2024 Recipient $2,500.00 1
PY2024 Principal investigator $266,245.58 45
PY2023 Recipient $11,425.21 3
PY2023 Principal investigator $223,016.82 28
PY2022 Principal investigator $7,677.75 5
PY2021 Principal investigator $11,693.75 8
PY2020 Principal investigator $18,165.50 12
PY2019 Principal investigator $35,329.70 13

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

8 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Recipient HEMA Biologics, LLC $7,130.00 11/14/2025 Covered Recipient Physician A Phase 3 Study of the Safety and Efficacy of Coagulation Factor VIIa (Recombinant) for the Prevention of Excessive Bleeding in Patients With Congenital Hemophilia A or B With Inhibitors to Factor VIII or IX Undergoing Elective Major Surgical Procedures SCOPE HIM No dispute reported 06/30/2026 1211421389
Recipient HEMA Biologics, LLC $4,600.00 11/14/2025 Covered Recipient Physician A Phase 3 Study of the Safety and Efficacy of Coagulation Factor VIIa (Recombinant) for the Prevention of Excessive Bleeding in Patients With Congenital Hemophilia A or B With Inhibitors to Factor VIII or IX Undergoing Elective Major Surgical Procedures SCOPE HIM No dispute reported 06/30/2026 1211421391
Principal investigator 1 ARGENX US, INC. $159.00 09/01/2025 Non-covered Recipient Entity
Tulane University School
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants with Primary Immune Thrombocytopenia No dispute reported 06/30/2026 1237160010
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $4,750.00 06/01/2025 Non-covered Recipient Entity
The Administrators Of The Tulane Educational Fund Dba On Behalfof Tulane University
BAY 949027, HEM-POWR Observational Study Evaluating Effectiveness and Safety of Real-World Treatment with Damoctocog alfa pegol in Previously Treated Patients with Hemophilia A No dispute reported 06/30/2026 1225408844
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $3,250.00 01/07/2025 Non-covered Recipient Entity
THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND
A TWO-PART OPEN-LABEL STUDY OF REGV131-LNP1265, A CRISPR/CAS9 BASED COAGULATION FACTOR IX GENE INSERTION THERAPY IN PARTICIPANTS WITH HEMOPHILIA B No dispute reported 06/30/2026 1184146116
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $5,000.00 01/07/2025 Non-covered Recipient Entity
THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND
A TWO-PART OPEN-LABEL STUDY OF REGV131-LNP1265, A CRISPR/CAS9 BASED COAGULATION FACTOR IX GENE INSERTION THERAPY IN PARTICIPANTS WITH HEMOPHILIA B No dispute reported 06/30/2026 1184146118
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $3,480.00 01/07/2025 Non-covered Recipient Entity
THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND
A TWO-PART OPEN-LABEL STUDY OF REGV131-LNP1265, A CRISPR/CAS9 BASED COAGULATION FACTOR IX GENE INSERTION THERAPY IN PARTICIPANTS WITH HEMOPHILIA B No dispute reported 06/30/2026 1184146120
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20,000.00 01/07/2025 Non-covered Recipient Entity
THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND
A TWO-PART OPEN-LABEL STUDY OF REGV131-LNP1265, A CRISPR/CAS9 BASED COAGULATION FACTOR IX GENE INSERTION THERAPY IN PARTICIPANTS WITH HEMOPHILIA B No dispute reported 06/30/2026 1184146122